{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:45:56Z","timestamp":1759481156364,"version":"3.38.0"},"reference-count":33,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGE"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4253\/wjge.v3.i4.71","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T06:29:54Z","timestamp":1305872994000},"page":"71","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage"],"prefix":"10.4253","volume":"3","author":[{"given":"Shotaro","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920; quiz 1943.","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroenterol 2007;41:437-444.","DOI":"10.1097\/MCG.0b013e31802e849f"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029.","DOI":"10.1080\/003655298750026697"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 2004;39:888-891.","DOI":"10.1007\/s00535-004-1417-7"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kusano M, Shimoyama Y, Kawamura O, Maeda M, Kuribayashi S, Nagoshi A, Zai H, Moki F, Horikoshi T, Toki M. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci 2007;52:1673-1677.","DOI":"10.1007\/s10620-006-9674-3"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Miyamoto M, Haruma K, Takeuchi K, Kuwabara M. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy. J Gastroenterol Hepatol 2008;23:746-751.","DOI":"10.1111\/j.1440-1746.2007.05218.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-141.","DOI":"10.1007\/BF02774209"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H. Progression of chronic atrophic gastritis associated with <italic>Helicobacter pylori<\/italic> infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.","DOI":"10.1002\/ijc.11680"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Serum pepsinogen and gastric cancer screening. Intern Med 2007;46:261-266.","DOI":"10.2169\/internalmedicine.46.6181"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Enomoto S, Maekita T, Ohata H, Yanaoka K, Oka M, Ichinose M. Novel risk markers for gastric cancer screening: Present status and future prospects. World J Gastrointest Endosc 2010;2:381-387.","DOI":"10.4253\/wjge.v2.i12.381"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Inverse background of <italic>Helicobacter pylori<\/italic> antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001;49:335-340.","DOI":"10.1136\/gut.49.3.335"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Shirota T, Kusano M, Kawamura O, Horikoshi T, Mori M, Sekiguchi T. <italic>Helicobacter pylori<\/italic> infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol 1999;34:553-559.","DOI":"10.1007\/s005350050372"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, Kajiyama G, Kawanishi M. Negative association between <italic>Helicobacter pylori<\/italic> infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000;5:24-29.","DOI":"10.1046\/j.1523-5378.2000.00003.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Toyota T, Shimosegawa T. <italic>Helicobacter pylori<\/italic> infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-334.","DOI":"10.1136\/gut.49.3.330"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754-815.","DOI":"10.1111\/j.1572-0241.2005.40966.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter 2008;13:352-360.","DOI":"10.1111\/j.1523-5378.2008.00624.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Grande M, Cadeddu F, Villa M, Attina GM, Muzi MG, Nigro C, Rulli F, Farinon AM. <italic>Helicobacter pylori<\/italic> and gastroesophageal reflux disease. World J Surg Oncol 2008;6:74.","DOI":"10.1186\/1477-7819-6-74"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Chen TS, Chang FY, Lee SD. Serodiagnosis of <italic>Helicobacter pylori<\/italic> infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol 1997;35:184-186.","DOI":"10.1128\/JCM.35.1.184-186.1997"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H, Oka H, Matsushima T, Takahashi K. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126:183-191.","DOI":"10.1016\/0009-8981(82)90034-1"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, Ozasa K, Kawai K. <italic>Helicobacter pylori<\/italic> infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-1387.","DOI":"10.1023\/A:1018833819860"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ichinose M, Yahagi N, Oka M, Ikeda H, Miki K, Omata M. Screening for gastric cancer in Japan. Cancer screening for common malignancies Totowa, New Jersey: Humana Press; 2001;87-102.","DOI":"10.1007\/978-1-59259-191-6_16"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.","DOI":"10.1053\/gast.1996.v111.pm8698230"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kusano M, Ino K, Yamada T, Kawamura O, Toki M, Ohwada T, Kikuchi K, Shirota T, Kimura M, Miyazaki M. Interobserver and intraobserver variation in endoscopic assessment of GERD using the &ldquo;Los Angeles&rdquo; classification. Gastrointest Endosc 1999;49:700-704.","DOI":"10.1016\/S0016-5107(99)70285-3"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Miwa H, Minoo T, Hojo M, Yaginuma R, Nagahara A, Kawabe M, Ohkawa A, Asaoka D, Kurosawa A, Ohkusa T. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther 2004;20 Suppl 1:112-117.","DOI":"10.1111\/j.1365-2036.2004.01990.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, Takeda H, Yoshida J, Graham DY. Atrophic changes of gastric mucosa are caused by <italic>Helicobacter pylori<\/italic> infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996;1:52-56.","DOI":"10.1111\/j.1523-5378.1996.tb00008.x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. <italic>Helicobacter pylori<\/italic> and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-1780.","DOI":"10.1093\/jnci\/87.23.1777"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, Hirota K, Kawabe T, Shiratori Y, Omata M. High prevalence of cytotoxin positive <italic>Helicobacter pylori<\/italic> in patients unrelated to the presence of peptic ulcers in Japan. Gut 1997;41:463-468.","DOI":"10.1136\/gut.41.4.463"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of <italic>Helicobacter pylori<\/italic> in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:73728.","DOI":"10.1136\/bmj.326.7392.737"},{"key":"ref29","unstructured":"Somi MH, Fattahi E, Fouladi RF, Karimi M, Bonyadi R, Baballou Z. An inverse relation between CagA+ strains of <italic>Heli-cobacter pylori<\/italic> infection and risk of erosive GERD. Saudi Med J 2008;29:393-396."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining <italic>Helicobacter pylori<\/italic> antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-768.","DOI":"10.1136\/gut.2004.055400"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005-1009.","DOI":"10.1080\/00365520510023260"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211.","DOI":"10.7326\/0003-4819-143-3-200508020-00006"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, Nishioka M. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol 2001;96:2026-2032.","DOI":"10.1111\/j.1572-0241.2001.03862.x"}],"container-title":["World Journal of Gastrointestinal Endoscopy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:57:24Z","timestamp":1741197444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5190\/full\/v3\/i4\/71.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4253\/wjge.v3.i4.71","relation":{},"ISSN":["1948-5190"],"issn-type":[{"type":"print","value":"1948-5190"}],"subject":[],"published":{"date-parts":[[2011]]}}}